Table 2.
Comparison of confirmed SARS and control patients in the SARS ICU with respect to demographics, comorbidities, and clinical features
| Variable | Patients with confirmed SARS (n = 14) | Patients without confirmed SARS (n = 36) | P |
|---|---|---|---|
| Age, y (range) | 67.0 ± 18.1 (24-84) | 76.3 ± 10.6 (41-91) | .122 |
| Male | 8 (57.1) | 29 (80.6) | .149 |
| HCW (%) | 2 (14.3) | 0 | .074 |
| APACHE II score on admission | 19.3 ± 8.8 | 21.1 ± 7.8 | .514 |
| Comorbidities | |||
| Diabetes mellitus | 8 (57.1) | 12 (33.3) | .198 |
| Hypertension | 4 (28.6) | 15 (41.7) | .522 |
| Cerebral vascular disease | 3 (21.4) | 14 (38.9) | .327 |
| Ischemic heart disease | 3 (21.4) | 8 (22.2) | 1.000 |
| Chronic renal failure | 1 (7.1) | 5 (13.9) | .663 |
| COPD | 1 (7.1) | 4 (11.1) | 1.000 |
| Selected symptoms and signs on admission to ICU | |||
| Fever | 13 (92.9) | 32 (88.9) | 1.000 |
| Diarrhea | 5 (35.7) | 25 (69.4) | .052 |
| Cough | 6 (42.9) | 18 (50.0) | .767 |
| Chills | 2 (14.3) | 2 (5.6) | .260 |
| Myalgia | 0 | 3 (8.4) | .538 |
| Headache | 0 | 2 (5.6) | .511 |
Data are presented as mean ± SD or n (%) unless otherwise indicated.